NumFin

Jiangsu Lanfeng Bio-chemical Co.,Ltd

Sümbol: 002513.SZ

SHZ

4.37

CNY

Turuhind täna

  • -4.9409

    P/E suhe

  • 0.0015

    PEG suhe

  • 1.49B

    MRK Cap

  • 0.00%

    DIV tootlus

Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Jiangsu Lanfeng Bio-chemical Co.,Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

0457.32484.6
331.5
280.4
582.5
246.2
489.4
428.2
171.7
150.3
256.1
367.3
870.9
99
71.9
24.7

balance-sheet.row.short-term-investments

00-4.9-4.6
-50.8
-79.4
2.1
0
0
-65.7
0
0
0
0
0
0
0
0.2

balance-sheet.row.net-receivables

0532.3229.2299.2
330.6
367.1
549.9
664.7
373.1
319.3
303.3
453.7
349.3
298.9
159.4
118.5
96.7
94.8

balance-sheet.row.inventory

0167.898.1132.7
129.8
146.6
147.8
178
199.2
253.2
239.8
258.3
273.1
121.4
111.2
53
49.4
54.6

balance-sheet.row.other-current-assets

043.5929.6
31.1
20.7
29.8
28.8
27.7
96.2
38.6
-15.9
-12
-8.7
-2.2
-8.4
-3.4
-3.6

balance-sheet.row.total-current-assets

01575.7360.3546
822.9
814.8
1310.1
1117.6
1089.5
1096.9
753.4
846.5
866.6
779
1139.3
262.1
214.6
170.5

balance-sheet.row.property-plant-equipment-net

01526.1868.2935.6
1255.6
1373.9
1588.9
1774.8
1781.7
1802.7
1701.4
1640.9
1387.8
928
487.6
343.2
206.9
180.4

balance-sheet.row.goodwill

0000
0
21.9
229.7
802.7
802.7
803.6
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

058.643.646.9
49.5
80.4
87.3
105.3
109.7
106.9
75.2
76.7
67.5
35.8
18.9
47.2
37.6
28.1

balance-sheet.row.goodwill-and-intangible-assets

058.643.646.9
49.5
102.3
317
908
912.4
910.5
75.2
76.7
67.5
35.8
18.9
47.2
37.6
28.1

balance-sheet.row.long-term-investments

08.912.39.5
54.4
81.5
0
0
76.4
65.7
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0126.896.5170.2
119.2
146.9
97.1
43.1
44.4
42
16.3
4.4
5
3.9
3.6
2.2
2.4
2.2

balance-sheet.row.other-non-current-assets

0103.694.619.8
9.4
183.3
213.8
188.8
145.7
115.7
64.9
20.1
4.6
5
5.4
0
0
0

balance-sheet.row.total-non-current-assets

01823.91115.31181.9
1488.1
1887.9
2216.8
2914.8
2960.7
2936.6
1857.8
1742.1
1464.9
972.7
515.5
392.6
246.9
210.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

03399.61475.51727.9
2311
2702.7
3526.9
4032.4
4050.1
4033.5
2611.2
2588.6
2331.5
1751.8
1654.8
654.6
461.5
381.2

balance-sheet.row.account-payables

01212.9543.2631.7
629.1
664.7
541.3
583.5
644.8
606.6
367.2
566.4
555.6
147.3
152
86
70
68.4

balance-sheet.row.short-term-debt

0203.3108.397.3
317.7
390
565.5
589.5
564.1
586
598.3
663.8
593
344.8
217
152.8
137.9
118.5

balance-sheet.row.tax-payables

022.54.81.6
1.7
20.9
24
42.3
33.4
27.1
8.5
-37.1
-59.2
-21.7
-7.4
-4.3
-2.1
7.1

balance-sheet.row.long-term-debt-total

0408.90.10.3
0
9.2
12.3
6.9
184.8
35
70
105
0
82
153.3
97.6
22.8
33.3

Deferred Revenue Non Current

0114.16.29
13.4
22.6
27.9
33.8
38.1
44
37
38.7
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0185.8333.18.3
9.4
66
475.1
122
38.5
31.6
23.2
31.6
25.6
34.2
35.1
34.5
29.2
48.9

balance-sheet.row.total-non-current-liabilities

0631.58116.1
17.2
147
287.8
204.3
227.4
293.1
422.8
143.7
15
87
158.3
97.6
23.6
34.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.50.10.3
145.4
111.6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

03148.911181061.3
1151.1
1567.3
1869.8
1499.2
1539.3
1626.6
1462.1
1402.2
1149.9
612.1
577.1
411.6
280.7
302.7

balance-sheet.row.preferred-stock

04915.30
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0373.9373.9340.1
340.1
340.1
340.1
340.1
340.1
340.1
213.1
213.1
213.1
133.2
74
55
55
55

balance-sheet.row.retained-earnings

0-2200-1867.7-1547
-1055.9
-1070.7
-554.1
320.8
296.2
190.5
259.2
301
302.3
275.5
222.9
153.8
103.3
15.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

05.5-15.374.6
76.7
66.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

01796.81851.41799
1799
1799
1871.1
1872.3
1874.6
1876.4
676.7
672.2
666.2
730.9
780.8
34.2
22.5
8.2

balance-sheet.row.total-stockholders-equity

025.2357.6666.6
1159.9
1135.4
1657.1
2533.2
2510.9
2407
1149
1186.2
1181.6
1139.7
1077.7
243
180.8
78.5

balance-sheet.row.total-liabilities-and-stockholders-equity

03399.61475.51727.9
2311
2702.7
3526.9
4032.4
4050.1
4033.5
2611.2
2588.6
2331.5
1751.8
1654.8
654.6
461.5
381.2

balance-sheet.row.minority-interest

0225.400
0
0
0
0
0
0
0
0.2
0
0
0
0
0
0

balance-sheet.row.total-equity

0250.7357.6666.6
1159.9
1135.4
1657.1
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

08.97.44.9
3.6
2.1
2.1
0
76.4
0.1
0.1
0.2
0
0
0
0
0
0.2

balance-sheet.row.total-debt

0612.2108.497.6
317.7
399.2
577.9
596.4
564.1
621
668.3
768.8
593
426.8
370.3
250.4
160.8
151.8

balance-sheet.row.net-debt

0154.984.413.1
-13.7
118.8
-4.6
350.2
74.6
192.8
496.6
618.5
336.9
59.4
-500.6
151.4
88.9
127.2

Rahavoogude aruanne

Jiangsu Lanfeng Bio-chemical Co.,Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

0-320.7-491.214.8
-516.6
-875
35.4
107.2
-68.8
-37.5
20.9
59.2
83.5
76.8
98.9
97.8
30.1

cash-flows.row.depreciation-and-amortization

095.8116.4123.9
142.9
159.1
148.6
139.8
128.1
160.4
132.6
73.8
48.9
35.9
25.2
23.7
15.2

cash-flows.row.deferred-income-tax

073.2-48.4-13.4
-50.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

09.748.413.4
50.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

082.39.60.6
47.4
-31.8
-232.4
32.7
120.2
-60.5
-157.2
-110.4
-149.4
-57.4
-5.4
-48.4
1.5

cash-flows.row.account-receivables

0-36.256.6488.9
58.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

018.7-25.511.1
-15
21.1
20.4
49.4
1.9
17
14.8
-151.7
-10.2
-57.8
0
1.6
-9.6

cash-flows.row.account-payables

026.626.8-486
54.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

073.2-48.4-13.4
-50.8
-52.9
-252.8
-16.8
118.3
-77.5
-172
41.3
-139.1
0.5
-5.4
-50.1
11

cash-flows.row.other-non-cash-items

0-4.6377-11
581.4
821
103.7
56.1
71.3
65.5
58.4
36.2
36.5
15.2
9.4
23.7
21.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-31.1-88.9-107.7
-91.9
-118.1
-123.2
-162.8
-109.8
-183.7
-264.1
-429.8
-515.1
-212
-158.2
-61
-64.3

cash-flows.row.acquisitions-net

07.43.7258.2
15.8
0
0
0
-136.4
0
-0.4
0
0
-2.1
0
0
0

cash-flows.row.purchases-of-investments

0-37.6-100
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0-7.4-3.70
0
0
0
2.7
0
0
0
0
0
0
0
0.1
0

cash-flows.row.other-investing-activites

058.93.770.2
-2.1
10
0.2
55.4
-61.1
1.4
27.3
15.4
12.1
55.4
0.2
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-9.8-95.2220.7
-78.3
-108
-122.9
-104.7
-307.3
-182.3
-237.2
-414.4
-503
-158.7
-158
-60.9
-64.3

cash-flows.row.debt-repayment

0-82-172.1-364.3
-380.8
-620.6
-493.3
-590.8
-687.2
-963.8
-725.4
-364.8
-218.3
-163.6
-138.2
-137.4
-111.8

cash-flows.row.common-stock-issued

0101.500
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-101.500
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-6-12.7-15.6
-19
-27
-52.8
-38.6
-49.4
-66.7
-59.6
-55.9
-47.5
-40.8
-27
-13.3
-14.1

cash-flows.row.other-financing-activites

0135.875.3113.7
280.9
650.3
441.3
414
1011.7
1124
901.5
531
274.8
1039.3
227.8
146.4
135.4

cash-flows.row.net-cash-used-provided-by-financing-activities

047.8-109.5-266.3
-118.9
2.8
-104.8
-215.4
275.1
93.5
116.6
110.3
9
834.9
62.6
-4.3
9.5

cash-flows.row.effect-of-forex-changes-on-cash

02.3-1-6.1
0.5
0.8
-16.4
6.5
8.2
2.6
-12.8
-4
-6.8
-2.4
-0.1
0.3
-3.2

cash-flows.row.net-change-in-cash

0-24-193.876.6
58.4
-31.1
-188.8
22.2
226.8
41.7
-78.8
-249.2
-481.1
744.4
32.6
31.8
10.2

cash-flows.row.cash-at-end-of-period

0933226.8
150.2
91.8
122.9
314.4
292.3
65.5
24.2
103
352.3
833.4
89
56.4
24.6

cash-flows.row.cash-at-beginning-of-period

033226.8150.2
91.8
122.9
311.7
292.3
65.5
23.8
103
352.3
833.4
89
56.4
24.6
14.3

cash-flows.row.operating-cash-flow

0-64.311.8128.3
255.1
73.3
55.3
335.7
250.8
128
54.7
58.9
19.6
70.5
128
96.8
68.2

cash-flows.row.capital-expenditure

0-31.1-88.9-107.7
-91.9
-118.1
-123.2
-162.8
-109.8
-183.7
-264.1
-429.8
-515.1
-212
-158.2
-61
-64.3

cash-flows.row.free-cash-flow

0-95.4-77.120.6
163.2
-44.8
-67.8
172.9
141
-55.7
-209.4
-371
-495.5
-141.5
-30.2
35.8
3.9

Kasumiaruande rida

Jiangsu Lanfeng Bio-chemical Co.,Ltd tulud muutusid võrreldes eelmise perioodiga NaN%. 002513.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

01741.61445.21443.9
1342
1504.4
1481.4
1850.6
1456.7
1010.4
1252.1
1372.1
1268.5
1143.3
914.1
627.5
908.1
550.6

income-statement-row.row.cost-of-revenue

01777.31435.81448.7
1157.8
1170.3
1120.9
1287.2
967.2
807
1109.5
1141.7
1009.2
899
711.8
462.5
712.9
451.6

income-statement-row.row.gross-profit

0-35.79.4-4.7
184.2
334.2
360.5
563.4
489.5
203.4
142.5
230.3
259.3
244.2
202.3
165
195.2
99

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-7.751.872.3
59.9
59.2
97.6
72.5
17.8
6.2
17.4
5.5
-0.6
9.4
1.6
24.1
14.6
4

income-statement-row.row.operating-expenses

0182.3119.3168.7
196.5
309.7
468.3
379.2
324
234.1
147.2
154.7
149.1
120.3
97.4
63.1
72.5
39.1

income-statement-row.row.cost-and-expenses

01959.61555.11617.4
1354.2
1479.9
1589.2
1666.4
1291.1
1041.1
1256.7
1296.5
1158.3
1019.3
809.1
525.6
785.4
490.7

income-statement-row.row.interest-income

017.82.2
1.4
1.5
3.1
2.8
1.5
1.8
2.6
3.1
0.7
12.5
1
0.7
0.8
0.7

income-statement-row.row.interest-expense

026.513.622.6
30.8
54.1
59
58.5
52.5
59.9
52.7
37.6
29.6
23.6
9.9
10.8
13.4
11.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-136.3-137.1-7.1
-23.8
-583.2
-814.4
-88.9
-43.6
-58.1
-39.9
-52.1
-41.6
-26.4
-14.3
14.8
-5.1
-13.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-7.751.872.3
59.9
59.2
97.6
72.5
17.8
6.2
17.4
5.5
-0.6
9.4
1.6
24.1
14.6
4

income-statement-row.row.total-operating-expenses

0-136.3-137.1-7.1
-23.8
-583.2
-814.4
-88.9
-43.6
-58.1
-39.9
-52.1
-41.6
-26.4
-14.3
14.8
-5.1
-13.4

income-statement-row.row.interest-expense

026.513.622.6
30.8
54.1
59
58.5
52.5
59.9
52.7
37.6
29.6
23.6
9.9
10.8
13.4
11.2

income-statement-row.row.depreciation-and-amortization

098.238.4463.3
123.9
142.9
159.1
148.6
139.8
128.1
160.4
132.6
73.8
48.9
35.9
25.2
23.7
15.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-346.7-109.9-531.8
26.6
23.4
-107.2
145.2
105.5
-94.9
-61.9
19.2
69.4
98.9
89.1
93.1
103.8
42.5

income-statement-row.row.income-before-tax

0-354.3-247-538.9
2.8
-559.8
-921.6
56.3
122
-88.8
-44.6
23.5
68.6
97.6
90.7
116.7
117.5
46.5

income-statement-row.row.income-tax-expense

0-6.673.7-47.7
-12.1
-43.3
-46.7
20.8
14.8
-20
-7.1
2.6
9.4
14.1
13.9
17.8
19.7
16.4

income-statement-row.row.net-income

0-332.3-320.7-491.2
14.8
-516.6
-875
35.4
107.2
-68.8
-37.5
21.1
59.2
83.5
76.8
98.9
97.8
30.1
Sarnased aktsiad
Sind võib huvitada ka:
004000.KS
LOTTE Fine Chemical Co., Ltd..
45700 KRW
KSC
GULPOLY.BO
Gulshan Polyols Limited.
195.9 INR
BSE
ZAP.WA
Zaklady Azotowe Pulawy S.A..
60.8 PLN
WSE
005420.KS
Cosmo Chemical Co., Ltd..
38950 KRW
KSC
PUNJABCHEM.BO
Punjab Chemicals and Crop Protection Limited.
982.5 INR
BSE
002971.SZ
Hubei Heyuan Gas Co.,Ltd..
25.84 CNY
SHZ
DIAMINESQ.BO
Diamines and Chemicals Limited.
539.45 INR
BSE
605399.SS
Jiang Xi Chenguang New Materials Co.,Ltd..
12.98 CNY
SHH
UNIP6.SA
Unipar Carbocloro S.A..
56.35 BRL
SAO
CHCC
China Chemical Corp..
0.0002 USD
PNK
300927.SZ
Nantong JiangTian Chemical Co., Ltd..
12.95 CNY
SHZ

Korduma kippuv küsimus

Mis on Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) koguvara?

Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) koguvara on 3399589930.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on -0.026.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -2.516.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.200.

Mis on ettevõtte kogutulu?

Kogutulu on -0.221.

Mis on Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -332260445.980.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 612238812.000.

Mis on tegevuskulude arv?

Tegevuskulud on 182291568.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.